Role of advanced imaging techniques in the evaluation of oncological therapies in patients with colorectal liver metastases.
Colorectal cancer metastases
Computed tomography
Magnetic resonance imaging
Parametric imaging
Positron emission tomography
Prediction response
Journal
World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448
Informations de publication
Date de publication:
21 Jan 2023
21 Jan 2023
Historique:
received:
06
10
2022
revised:
25
11
2022
accepted:
03
01
2023
entrez:
23
1
2023
pubmed:
24
1
2023
medline:
25
1
2023
Statut:
ppublish
Résumé
In patients with colorectal liver metastasis (CRLMs) unsuitable for surgery, oncological treatments, such as chemotherapy and targeted agents, can be performed. Cross-sectional imaging [computed tomography (CT), magnetic resonance imaging (MRI), 18-fluorodexoyglucose positron emission tomography with CT/MRI] evaluates the response of CRLMs to therapy, using post-treatment lesion shrinkage as a qualitative imaging parameter. This point is critical because the risk of toxicity induced by oncological treatments is not always balanced by an effective response to them. Consequently, there is a pressing need to define biomarkers that can predict treatment responses and estimate the likelihood of drug resistance in individual patients. Advanced quantitative imaging (diffusion-weighted imaging, perfusion imaging, molecular imaging) allows the
Identifiants
pubmed: 36688023
doi: 10.3748/wjg.v29.i3.521
pmc: PMC9850941
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
521-535Informations de copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Références
Br J Radiol. 2020 Nov 1;93(1115):20200751
pubmed: 32915647
AJNR Am J Neuroradiol. 2010 May;31(5):809-16
pubmed: 20395383
AJR Am J Roentgenol. 2016 Sep;207(3):W26-32
pubmed: 27303858
Eur J Radiol. 2012 Dec;81(12):3870-6
pubmed: 22944331
Br J Radiol. 2013 Oct;86(1030):20130281
pubmed: 23995873
Ann Oncol. 2012 Jul;23(7):1687-93
pubmed: 22112970
Cancer Res Treat. 2016 Oct;48(4):1210-1221
pubmed: 26987390
Br J Radiol. 1998 Mar;71(843):276-81
pubmed: 9616236
J Venom Anim Toxins Incl Trop Dis. 2020 Sep 04;26:e20200011
pubmed: 32952531
Eur J Radiol. 2003 Mar;45(3):208-13
pubmed: 12595105
Br J Radiol. 2011 Dec;84 Spec No 2:S112-20
pubmed: 22433822
Radiol Med. 2019 Sep;124(9):877-886
pubmed: 31172448
ESMO Open. 2021 Aug;6(4):100208
pubmed: 34325107
Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1214-22
pubmed: 23636802
NMR Biomed. 2007 Apr;20(2):128-40
pubmed: 17006886
Int J Cancer. 2012 May 15;130(10):2359-65
pubmed: 21780098
Eur Radiol. 2019 Jan;29(1):458-467
pubmed: 29922934
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
World J Radiol. 2015 Jul 28;7(7):157-69
pubmed: 26217455
HPB (Oxford). 2018 Feb;20(2):120-127
pubmed: 29196021
Oncologist. 2004;9 Suppl 5:31-40
pubmed: 15591420
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
J Belg Soc Radiol. 2018 Apr 20;102(1):40
pubmed: 30039052
Eur J Radiol. 2021 Apr;137:109609
pubmed: 33647779
Eur J Radiol. 2016 Oct;85(10):1867-1874
pubmed: 27666629
Eur Radiol. 2020 Jan;30(1):291-300
pubmed: 31209620
Acad Radiol. 2021 Nov;28 Suppl 1:S73-S80
pubmed: 33008734
AJR Am J Roentgenol. 2007 Apr;188(4):1001-8
pubmed: 17377036
Cancer Imaging. 2019 Jun 19;19(1):39
pubmed: 31217036
Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1441-8
pubmed: 22699529
Cancer Lett. 2020 Jul 1;481:55-62
pubmed: 32251707
Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1594-603
pubmed: 17492447
Abdom Imaging. 2010 Oct;35(5):511-21
pubmed: 19562412
Eur Radiol. 2016 Jul;26(7):2009-18
pubmed: 26494642
Eur J Radiol. 2020 Sep;130:109149
pubmed: 32659615
Magn Reson Med. 2005 Jun;53(6):1432-40
pubmed: 15906300
Radiology. 2005 Mar;234(3):756-64
pubmed: 15734932
Eur J Radiol. 2011 Dec;80(3):e278-83
pubmed: 21251785
Acta Radiol. 2012 Dec 1;53(10):1118-26
pubmed: 23051638
Cancer Chemother Pharmacol. 2013 Jul;72(1):209-15
pubmed: 23670642
Nat Clin Pract Oncol. 2008 Apr;5(4):220-33
pubmed: 18301415
World J Hepatol. 2022 Jan 27;14(1):244-259
pubmed: 35126852
Eur J Radiol. 2012 Nov;81(11):3542-50
pubmed: 22459347
World J Gastroenterol. 2011 Dec 21;17(47):5133-49
pubmed: 22215937
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:1339-1342
pubmed: 33018236
Br J Cancer. 2012 Jun 5;106(12):1926-33
pubmed: 22596235
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5524-9
pubmed: 15805192
Ann Surg Oncol. 2012 Apr;19(4):1292-301
pubmed: 21922338
Int J Cancer. 2020 Dec 1;147(11):3215-3223
pubmed: 32875550
J Clin Oncol. 2008 Oct 1;26(28):4572-8
pubmed: 18824708
Med Phys. 2021 Jan;48(1):513-522
pubmed: 33119899
Cancer Cell. 2018 Jul 9;34(1):148-162.e7
pubmed: 29990497
Ann Oncol. 2009 Jun;20(6):1057-61
pubmed: 19164458
Anticancer Drugs. 2004 Mar;15(3):229-33
pubmed: 15014355
World J Gastroenterol. 2019 Sep 21;25(35):5233-5256
pubmed: 31558870
J Magn Reson Imaging. 2014 Feb;39(2):317-25
pubmed: 23723012
Abdom Radiol (NY). 2019 Jan;44(1):65-71
pubmed: 29967982
Tumour Biol. 2016 Mar;37(3):3871-7
pubmed: 26476536
Br J Radiol. 2020 Apr;93(1108):20190948
pubmed: 32101448
Abdom Radiol (NY). 2018 Dec;43(12):3301-3306
pubmed: 29666951
Gastroenterol Res Pract. 2020 Jul 18;2020:3435673
pubmed: 32733550
BJS Open. 2020 Aug;4(4):685-692
pubmed: 32543788
Front Oncol. 2021 Jul 26;11:587856
pubmed: 34386413
Radiology. 2008 Sep;248(3):894-900
pubmed: 18710982
Ann Gastroenterol Surg. 2019 Jan 14;3(1):50-56
pubmed: 30697610
Clin Imaging. 2017 Jan - Feb;41:1-6
pubmed: 27721090
PLoS One. 2015 Apr 01;10(4):e0120823
pubmed: 25831053
J Natl Compr Canc Netw. 2019 May 1;17(5.5):599-601
pubmed: 31117039